Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

More than half of all cancer patients receive chemotherapy, however, some of them easily acquire drug resistance. Resistance to chemotherapy has become a massive obstacle to achieve high rates of pathological complete response during cancer therapy. S-phase kinase-associated protein 2 (Skp2), as an E3 ligase, was found to be highly correlated with drug resistance and poor prognosis. In this review, we summarize the mechanisms that Skp2 confers to drug resistance, including the Akt-Skp2 feedback loop, Skp2-p27 pathway, cell cycle and mitosis regulation, EMT (epithelial-mesenchymal transition) property, enhanced DNA damage response and repair, etc. We also addressed novel molecules that either inhibit Skp2 expression or target Skp2-centered interactions, which might have vast potential for application in clinics and benefit cancer patients in the future.


Ting Wu, Xinsheng Gu, Hongmei Cui. Emerging Roles of SKP2 in Cancer Drug Resistance. Cells. 2021 May 10;10(5)

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 34068643

View Full Text